Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.
Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.
复制标题
苏型哌甲酯的叠氮基碘-N-苄基衍生物(利他林,Concerta):合理设计、合成、药理学评价和多巴胺转运蛋白光亲和标记。
DOI:
10.1016/j.bmc.2010.11.002
复制
发表时间:
2011
影响因子:
3.5
通讯作者:
Deutsch,HowardM
中科院分区:
文献类型:
--
作者:
Lapinsky,DavidJ;Velagaleti,Ranganadh;Yarravarapu,Nageswari;Liu,Yi;Huang,Yurong;Surratt,ChristopherK;Lever,JohnR;Foster,JamesD;Acharya,Rejwi;Vaughan,RoxanneA;Deutsch,HowardM
In contrast to tropane-based compounds such as benztropine and cocaine, non-tropane-based photoaffinity ligands for the dopamine transporter (DAT) are relatively unexplored. Towards addressing this knowledge gap, ligands were synthesized in which the piperidine nitrogen of 3- and 4-iodomethylphenidate was substituted with a benzyl group bearing a photoreactive azide. Analog (±)-3a demonstrated modest DAT affinity and a radioiodinated version was shown to bind covalently to rat striatal DAT and hDAT expressed in cultured cells. Co-incubation of (±)-3a with nonradioactive d-(+)-methylphenidate or (−)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane (β-CFT, WIN-35,428, a cocaine analog) blocked DAT labeling. Compound (±)-3a represents the first successful example of a DAT photoaffinity ligand based on the methylphenidate scaffold. Such ligands are expected to assist in mapping non-tropane ligand-binding pockets within plasma membrane monoamine transporters.